157 related articles for article (PubMed ID: 38087188)
1. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism.
Watanabe D; Morimoto S; Morishima N; Ichihara A
Endocrine; 2024 Apr; 84(1):245-252. PubMed ID: 38087188
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic Outcomes of Primary Aldosteronism Patients Receiving Adrenalectomy or Spironolactone Treatments].
Xu C; Chen T; Mo D; Zhang T; Zhou F; Tian H; Ren Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1227-1232. PubMed ID: 38162054
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease.
Nakano Y; Murakami M; Hara K; Fukuda T; Horino M; Takeuchi A; Niitsu Y; Shiba K; Tsujimoto K; Komiya C; Yokoyama M; Ikeda K; Yoshimoto T; Fujii Y; Yamada T
Clin Endocrinol (Oxf); 2023 Mar; 98(3):323-331. PubMed ID: 36367014
[TBL] [Abstract][Full Text] [Related]
4. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
[TBL] [Abstract][Full Text] [Related]
5. [Clinical Characteristics of Aldosterone Producing Adenoma and Idiopathic Hyperaldosteronism with Obstructive Sleep Apnea Hypopnea Syndrome].
Zuo FJ; Zhou XH; Ren Y; Chen T; Tian HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):298-303. PubMed ID: 32543133
[TBL] [Abstract][Full Text] [Related]
6. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
8. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects.
Spyroglou A; Handgriff L; Müller L; Schwarzlmüller P; Parasiliti-Caprino M; Fuss CT; Remde H; Hirsch A; O'Toole SM; Thuzar M; Petramala L; Letizia C; Deflorenne E; Amar L; Vrckovnik R; Kocjan T; Zhang CD; Li D; Singh S; Katabami T; Yoneda T; Murakami M; Wada N; Inagaki N; Quinkler M; Ghigo E; Maccario M; Stowasser M; Drake WM; Fassnacht M; Bancos I; Reincke M; Naruse M; Beuschlein F
Eur J Endocrinol; 2022 Sep; 187(3):361-372. PubMed ID: 35895721
[TBL] [Abstract][Full Text] [Related]
9. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
Matsumoto T; Oki K; Kajikawa M; Nakashima A; Maruhashi T; Iwamoto Y; Iwamoto A; Oda N; Hidaka T; Kihara Y; Kohno N; Chayama K; Goto C; Aibara Y; Noma K; Liao JK; Higashi Y
Hypertension; 2015 Apr; 65(4):841-8. PubMed ID: 25624340
[TBL] [Abstract][Full Text] [Related]
10. Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
Berge C; Courand PY; Harbaoui B; Paget V; Khettab F; Bricca G; Fauvel JP; Lantelme P
J Hypertens; 2015 Jan; 33(1):118-25. PubMed ID: 25333683
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of Different Doses of ACTH Used in ACTH Stimulation Test to Determine the Subtypes of Primary Aldosteronism].
Qiu P; Zang L; Zhang L; Lyu Z; Mu Y; Guo Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):210-216. PubMed ID: 38322542
[TBL] [Abstract][Full Text] [Related]
13. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group).
Kuo CC; Wu VC; Huang KH; Wang SM; Chang CC; Lu CC; Yang WS; Tsai CW; Lai CF; Lee TY; Lin WC; Wu MS; Lin YH; Chu TS; Lin CY; Chang HW; Wang WJ; Kao TW; Chueh SC; Wu KD; Taipai Study Group
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):348-57. PubMed ID: 21393359
[TBL] [Abstract][Full Text] [Related]
14. Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.
Kobayashi H; Abe M; Nakamura Y; Takahashi K; Fujita M; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Wada N; Ichijo T; Katabami T; Ogawa Y; Kawashima J; Yoshimoto T; Sone M; Inagaki N; Watanabe M; Kamemura K; Matsuda Y; Izawa S; Tanabe M; Tanabe A; Suzuki T; Naruse M;
Hypertension; 2019 Sep; 74(3):630-638. PubMed ID: 31327258
[TBL] [Abstract][Full Text] [Related]
15. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
[TBL] [Abstract][Full Text] [Related]
18. Primary aldosteronism -- screening, diagnosis and therapy.
Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.
Chen KM; Lee BC; Chen PT; Liu KL; Lin KH; Chang CC; Wu TH; Hong JS; Lin YH
Front Endocrinol (Lausanne); 2021; 12():647184. PubMed ID: 34335463
[TBL] [Abstract][Full Text] [Related]
20. Primary aldosteronism - treatment options.
Young WF
Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S102-8. PubMed ID: 12914736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
